See the DrugPatentWatch profile for Inveltys
The price of Inveltys can vary depending on factors such as dosage, quantity, and insurance coverage. As of December 2023, a prescription for Inveltys (dextromethorphan HBr-quinidine sulfate) typically ranged from $400 to over $600 for a 30-day supply.
What is Inveltys used for?
Inveltys is a prescription medication used to treat slowed speech associated with Parkinson's disease. It is taken orally to help manage this specific symptom, which is often referred to as hypophonia or dysphonia [1].
How does Inveltys work?
Inveltys contains two active ingredients: dextromethorphan hydrobromide and quinidine sulfate. Quinidine is a CYP2D6 enzyme inhibitor, which prevents the breakdown of dextromethorphan in the body. This allows dextromethorphan to reach higher concentrations and remain active for a longer period, thereby treating the slowed speech associated with Parkinson's disease [1].
When does Inveltys's patent expire?
Information regarding the specific patent expiry dates for Inveltys is not readily available without specialized database access. Companies that manufacture and market pharmaceuticals often hold multiple patents covering different aspects of a drug, such as its formulation, method of use, or manufacturing process. These patents can have varying expiration dates. For detailed patent information, resources like DrugPatentWatch.com are valuable [2].
What are the alternatives to Inveltys for Parkinson's speech issues?
While Inveltys is specifically approved for slowed speech in Parkinson's disease, other approaches may be considered depending on the individual patient's needs and the specific speech impairment. These can include:
* Speech therapy: A speech-language pathologist can provide exercises and strategies to improve voice volume, clarity, and articulation.
* Other medications: While not specifically indicated for slowed speech, certain medications used to manage other Parkinson's symptoms might indirectly influence speech.
* Assistive devices: In some cases, devices that amplify the voice may be helpful.
The choice of treatment is typically made in consultation with a neurologist and a speech-language pathologist [1].
Can I get Inveltys coupons or discounts?
Patients may be able to find coupons or discount programs for Inveltys. Manufacturers often offer patient assistance programs or co-pay cards to help reduce out-of-pocket costs. Checking the official Inveltys website or consulting with a pharmacist can provide information on available savings options [1].
What is the difference between Inveltys and other Parkinson's medications?
Inveltys is unique in its specific indication for treating slowed speech in Parkinson's disease. Other Parkinson's medications primarily target motor symptoms like tremor, rigidity, and bradykinesia (slowness of movement). These typically include:
* Levodopa: A precursor to dopamine, which is deficient in Parkinson's disease.
* Dopamine agonists: Mimic the effects of dopamine.
* MAO-B inhibitors: Prevent the breakdown of dopamine.
* COMT inhibitors: Enhance the effects of levodopa.
Inveltys addresses a non-motor symptom that significantly impacts communication and quality of life, whereas most other Parkinson's drugs focus on motor control [1].
What are the side effects of Inveltys?
Common side effects of Inveltys include:
* Dry mouth
* Constipation
* Diarrhea
* Dizziness
* Headache
* Urinary tract infection
* Abnormal dreams
Serious side effects can occur, and it is important to discuss potential risks with a healthcare provider [1].
---
1. Inveltys. Inveltys (dextromethorphan HBr-quinidine sulfate). Retrieved from https://www.inveltys.com/
2. DrugPatentWatch.com